Safinamide methansulfonate (Xadago®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Safinamide methansulfonate
Brand Xadago®
Indication For the treatment of adult patients with idiopathic Parkinson’s disease.
Assessment Process
Rapid review commissioned 14/06/2016
Rapid review completed 06/07/2016
Rapid review outcome Reimbursement Not Recommended